Insulin-like growth factors I and II: some biological actions and receptor binding characteristics of two purified constituents of nonsuppressible insulin-like activity of human serum.
about
Characterization of insulin-like-growth factor II (IGF II) mRNA positive hepatic altered foci and IGF II expression in hepatocellular carcinoma during diethylnitrosamine-induced hepatocarcinogenesis in rats.Human conditions of insulin-like growth factor-I (IGF-I) deficiencyTwo types of receptor for insulin-like growth factors in mammalian brainComparison of the metabolic effects of recombinant human insulin-like growth factor-I and insulin. Dose-response relationships in healthy young and middle-aged adults.Sequential addition of platelet factor and plasma to BALB/c 3T3 fibroblast cultures stimulates somatomedin-C binding early in cell cycle.Regulation of lipoprotein lipase in primary cultures of isolated human adipocytesReceptors and growth-promoting effects of insulin and insulinlike growth factors on cells from bovine retinal capillaries and aorta.Identification of persistent defects in insulin receptor structure and function capillary endothelial cells from diabetic rats.Human colony-forming units-erythroid do not require accessory cells, but do require direct interaction with insulin-like growth factor I and/or insulin for erythroid developmentAcute effects of insulin-like growth factor I on glucose and amino acid metabolism in the awake fasted rat. Comparison with insulin.Expression of a synthetic gene encoding human insulin-like growth factor I in cultured mouse fibroblasts.Dual regulation of glycogen metabolism by insulin and insulin-like growth factors in human hepatoma cells (HEP-G2). Analysis with an anti-receptor monoclonal antibody.Regulation of insulin-like growth factor II receptors by growth hormone and insulin in rat adipocytes.Bone tissue engineering: recent advances and promising therapeutic agents.Somatomedin receptor of human placenta: solubilization, photolabeling, partial purification, and comparison with insulin receptor.Insulin-like growth factor I binding in hepatocytes from human liver, human hepatoma, and normal, regenerating, and fetal rat liverEfficient secretion and purification of human insulin-like growth factor I with a gene fusion vector in Staphylococci.Insulin and insulin-like growth factor II permit nerve growth factor binding and the neurite formation response in cultured human neuroblastoma cells.Insulin activates the appearance of insulin-like growth factor II receptors on the adipocyte cell surface.Structure of the insulin-like growth factor receptor in chicken embryo fibroblasts.Isolation of the human insulin-like growth factor I gene using a single synthetic DNA probe.Acute metabolic effects and half-lives of intravenously administered insulinlike growth factors I and II in normal and hypophysectomized rats.Radioimmunological determination of insulinlike growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia.Direct demonstration of separate receptors for growth and metabolic activities of insulin and multiplication-stimulating activity (an insulinlike growth factor) using antibodies to the insulin receptor.Inhibition of the action of nonsuppressible insulin-like activity on isolated rat fat cells by binding to its carrier proteinBerson, Yalow, and the JCI: the agony and the ecstasy.The role of insulin-like growth factor during a postischemic period - new insights into pathophysiologic pathways in cardiac tissue.Amino acid sequence of a variant pro-form of insulin-like growth factor II.Insulin-related genes expressed in human placenta from normal and diabetic pregnancies.Somatomedins: chemical and functional characteristics of the different molecular forms.Somatomedins and other serum growth factors: a review of current concepts.The effects of infusion of insulinlike growth factor (IGF) I, IGF-II, and insulin on glucose and protein metabolism in fasted lambs.Insulin and insulin-like growth factors in diabetes mellitus.Insulin-like growth factors in central nervous system tumors.Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease.Enhancement of human granulopoiesis in vitro by biosynthetic insulin-like growth factor I/somatomedin C and human growth hormoneRegulation of insulin-like growth factor-I expression in mouse preadipocyte Ob1771 cells.Insulin and insulin-like growth factor I exert different effects on plasminogen activator production or cell growth in the ovine thyroid cell line OVNIS.Serum factors, growth factors and UDP-sugar metabolism in bovine articular cartilage chondrocytes.Insulin-like growth factor-II: new roles for an old actor.
P2860
Q24811580-861A04D5-3770-4F74-85A1-3E28D6080ED1Q26822806-A9C89661-515E-4173-A819-C9F3F0F70354Q33932084-0B982027-D54F-4900-98CA-E74852353157Q34132745-E3B17D2A-9713-42CB-93A0-A154B3E6B7D8Q34248988-2B1F07DA-CFA0-4933-BE30-D4E8CC78D8B1Q34523925-983A468E-E8F4-4053-82BF-DED9F7612219Q34537980-3D62D6A4-CDAF-4C3E-A1E4-2DBFC4AFB9FDQ34563858-B441F660-51D6-43FF-B015-E69A72E040A0Q34573311-F03497E4-66B1-453C-AAA7-0329253D4679Q34573364-BB808DE9-F3E1-42F2-9EB7-59C135A3988EQ34616683-1F06EF9B-5611-46E5-8483-0AC67D881906Q34617726-FF319345-6D43-469C-8089-961CD20BEFA1Q34626658-CB10FF1F-C544-4073-9AB1-E03834841AECQ35144021-47423656-A7F0-48E1-BAF8-5FAB0BDAC124Q35399674-B7E98D72-A9D7-4A27-BE78-DEEED3F22221Q35810600-12F5F78A-93EE-4462-8C95-B29702B8884BQ36135940-04523C0E-BEDB-48B3-B0EF-123E47ACACD7Q36258189-D9BCDB2E-D44C-442F-A739-9AE23E1483DCQ36264280-B2FEB1B0-8B31-4727-AC36-7078F06AB0A2Q36287210-A63EBBB3-8A59-480C-9871-7C3DC543454BQ36594137-7E95B55C-A435-41A1-883C-6A1DA66A8C01Q36993997-4D617A89-F2A4-4C64-BE3A-4B3A1D5AF429Q37005523-F39CF63C-F0EE-435A-B02C-B477C75468F9Q37024018-9CACBF1A-4E63-4DE5-AF77-E5E617664A63Q37038232-34CAE4C7-2161-40CE-8542-6CDA5A025A54Q37574644-90CF25BD-7124-4BFF-B328-1E01DD44A4B9Q37608512-40205291-370D-44C7-BCDC-092456ACA9C0Q37687829-7CB3C28D-B798-48C9-9073-F1DCAD3B45F4Q37690652-F9389A4B-835A-4C08-91E9-ABB3615EFCE8Q38279963-4CA7EE5B-DE9F-48D5-AA3E-D706EEA2402CQ40123750-DF98A10C-2243-4113-B637-B39CB0DF7405Q40341473-743D92F8-65C3-49DD-A204-48C0C761E542Q40449358-CC548977-B442-4050-B543-805EC1255D73Q40491213-5A6EF568-FBA4-497B-876C-B7C08A2836B5Q40618944-749D2520-4016-4D0A-AE50-58440619407CQ41016804-234A353C-DC08-4079-98EB-10241FE87B4EQ41204538-37DC5FE5-3CC1-41FC-9D44-C8FD8065EE6EQ41658074-27350150-7418-4090-BB87-5424D208ED7CQ41807262-8F96A8EF-AD44-474D-A032-559F81721938Q42035390-5EE35020-9EC7-41CB-B388-4BA00293E047
P2860
Insulin-like growth factors I and II: some biological actions and receptor binding characteristics of two purified constituents of nonsuppressible insulin-like activity of human serum.
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
1978年论文
@zh
1978年论文
@zh-cn
name
Insulin-like growth factors I ...... -like activity of human serum.
@en
type
label
Insulin-like growth factors I ...... -like activity of human serum.
@en
prefLabel
Insulin-like growth factors I ...... -like activity of human serum.
@en
P2093
P1433
P1476
Insulin-like growth factors I ...... -like activity of human serum.
@en
P2093
P304
P356
10.1111/J.1432-1033.1978.TB12377.X
P407
P577
1978-06-01T00:00:00Z